![](/img/cover-not-exists.png)
A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)
Negoro, S, Noda, K, Nishiwaki, Y, Kawahara, M, Tamura, T, Sugiura, T, Yokayama, A, Mori, K, Fukuoka, M, Yoshimura, K, Saijo, NVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80095-1
Date:
September, 2000
File:
PDF, 112 KB
english, 2000